Info

Gryphon Sciences is a private company focused on the development of synthetic biotherapeutics, including performance enhanced versions of protein drugs. Gryphon completed its last round of financing in January of 2002. We were pleased to welcome The Sprout Group to the team, as well as encouraged by the increased participation of our previous investors.